A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular CarcinomaLipika Goyal, Andrew X. Zhu, Hui Zheng et al.|Clinical Cancer Research|2018Cited by 82
Site- and allele-specific polycomb dysregulation in T-cell leukaemiaJean‐Marc Navarro, Bertrand Nadel, Myriam Koubi et al.|Nature Communications|2015Cited by 58